ACCORD
ACCORD is a seamless, Phase 2, adaptive, randomised controlled platform study, designed to rapidly test candidate agents in the treatment of COVID-19.
ACCORD is a seamless, Phase 2, adaptive, randomised controlled platform study, designed to rapidly test candidate agents in the treatment of COVID-19.
CLASP (Cancer: Life Affirming Survivorship support in Primary care Programme) aims to evaluate an online intervention offering lifestyle and wellbeing support for cancer survivors, called Renewed.
The ECO (Eczema Care Online) study aims to promote effective eczema self-care.
ENeRgy (Exercise and Nutritional Rehabilitation in patients with cancer) study will investigate whether an exercise and nutrition based rehabilitation programme is feasible in patients with advanced cancer.
The HOME-BP study aims to assess the effectiveness of a digital intervention the self-management of high blood pressure.
The PALS study aims to assess the effectiveness of a web-based social networking tool to reduce the negative impacts of loneliness and social isolation.
RECON will investigate the use of a website called ‘Active Brains’ which aims preventing problems with memory, concentration and reasoning which may assist in slowing cognitive decline in older adults.
The REDUCE research programme aims to identify feasible, safe, effective, and cost-effective ways of helping patients taking long-term antidepressants taper off and stop treatment, when appropriate.
The STREAM study aims to assess the effectiveness of the ‘Eat well, feel well, stay well’ intervention in older adults living at home who are at risk of malnutrition.